US & Europe Gene Editing Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US & Europe Gene Editing Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US & Europe Gene Editing Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US & Europe Gene Editing Market Regional Analysis

6.2 US & Europe Gene Editing Market Revenue 2020-2030 (US$ Million)

6.3 US & Europe Gene Editing Market Forecast Analysis

7. US & Europe Gene Editing Market Analysis – by Technology

7.1 CRISPR

7.1.1 Overview
7.1.2 CRISPR: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 TALEN

7.2.1 Overview
7.2.2 TALEN: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Antisense

7.3.1 Overview
7.3.2 Antisense: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Zinc Finger Nucleases

7.4.1 Overview
7.4.2 Zinc Finger Nucleases: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. US & Europe Gene Editing Market Analysis – by Product and Services

8.1 Reagents and Consumables

8.1.1 Overview
8.1.2 Reagents and Consumables: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Instruments

8.2.1 Overview
8.2.2 Instruments: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. US & Europe Gene Editing Market Analysis – by Application

9.1 Cell Line Engineering

9.1.1 Overview
9.1.2 Cell Line Engineering: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Genetic Engineering

9.2.1 Overview
9.2.2 Genetic Engineering: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Diagnostic Applications

9.3.1 Overview
9.3.2 Diagnostic Applications: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.4 Drug Discovery

9.4.1 Overview
9.4.2 Drug Discovery: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. US & Europe Gene Editing Market Analysis – by End User

10.1 Pharmaceutical & Biotechnology Companies

10.1.1 Overview
10.1.2 Pharmaceutical & Biotechnology Companies: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Academic and Research Institutes

10.2.1 Overview
10.2.2 Academic and Research Institutes: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.3 Clinical Research Organizations

10.3.1 Overview
10.3.2 Clinical Research Organizations: US & Europe Gene Editing Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. US & Europe Gene Editing Market – United State Analysis

11.1 Overview

11.2 Europe

11.2.1 US & Europe Gene Editing Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 US & Europe Gene Editing Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.1.2 UK: US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.1.3 UK: US & Europe Gene Editing Market Breakdown, by Application
11.2.1.1.4 UK: US & Europe Gene Editing Market Breakdown, by End User

11.2.1.2 Germany: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.2.2 Germany: US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.2.3 Germany: US & Europe Gene Editing Market Breakdown, by Application
11.2.1.2.4 Germany: US & Europe Gene Editing Market Breakdown, by End User

11.2.1.3 France: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.3.2 France: US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.3.3 France: US & Europe Gene Editing Market Breakdown, by Application
11.2.1.3.4 France: US & Europe Gene Editing Market Breakdown, by End User

11.2.1.4 Russia: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.4.2 Russia: US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.4.3 Russia: US & Europe Gene Editing Market Breakdown, by Application
11.2.1.4.4 Russia: US & Europe Gene Editing Market Breakdown, by End User

11.2.1.5 Italy: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.5.2 Italy: US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.5.3 Italy: US & Europe Gene Editing Market Breakdown, by Application
11.2.1.5.4 Italy: US & Europe Gene Editing Market Breakdown, by End User

11.2.1.6 Rest of Europe : US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Technology
11.2.1.6.2 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Product and Services
11.2.1.6.3 Rest of Europe : US & Europe Gene Editing Market Breakdown, by Application
11.2.1.6.4 Rest of Europe : US & Europe Gene Editing Market Breakdown, by End User

11.3 United State

11.3.1 US & Europe Gene Editing Market Breakdown, by Key Country, 2023 and 2030 (%)
11.3.1.1 US & Europe Gene Editing Market – Revenue and Forecast Analysis – by Country
11.3.1.1 United State: US & Europe Gene Editing Market – Revenue and Forecast to 2030 (US$ Million)

11.3.1.1.1 United State: US & Europe Gene Editing Market Breakdown, by Technology
11.3.1.1.2 United State: US & Europe Gene Editing Market Breakdown, by Product and Services
11.3.1.1.3 United State: US & Europe Gene Editing Market Breakdown, by Application
11.3.1.1.4 United State: US & Europe Gene Editing Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Merck KGaA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Lonza Group AG

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Horizon Discovery Group plc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 INTEGRATED DNA TECHNOLOGIES, INC.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 GenScript Biotech Corporation

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 New England Biolabs

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Eurofins Scientific SE

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 CRISPR Therapeutics

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Editas Medicine Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 ElevateBio LLC

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

US & Europe Gene Editing Market